Treatment of depressive disorders
US7977377B2 · kind B2 · utility
9Cited by
17References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2007 |
| Grant date | Jul 12, 2011 |
| Priority date | — |
| Expiry date | Nov 13, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds the treatment of depressive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.